These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16340662)

  • 1. Cardioprotective mechanisms of the kallikrein-kinin system in diabetic cardiopathy.
    Spillmann F; Van Linthout S; Schultheiss HP; Tschöpe C
    Curr Opin Nephrol Hypertens; 2006 Jan; 15(1):22-9. PubMed ID: 16340662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy.
    Tschöpe C; Walther T; Escher F; Spillmann F; Du J; Altmann C; Schimke I; Bader M; Sanchez-Ferrer CF; Schultheiss HP; Noutsias M
    FASEB J; 2005 Dec; 19(14):2057-9. PubMed ID: 16129698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the renal kallikrein-kinin system in diabetic nephropathy.
    Riad A; Zhuo JL; Schultheiss HP; Tschöpe C
    Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):22-6. PubMed ID: 17143067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides.
    Campbell DJ
    Braz J Med Biol Res; 2000 Jun; 33(6):665-77. PubMed ID: 10829095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophils engage the kallikrein-kinin system to open up the endothelial barrier in acute inflammation.
    Kenne E; Rasmuson J; Renné T; Vieira ML; Müller-Esterl W; Herwald H; Lindbom L
    FASEB J; 2019 Feb; 33(2):2599-2609. PubMed ID: 30281335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kallikrein-kinin system in diabetic retinopathy: lessons for the kidney.
    Phipps JA; Feener EP
    Kidney Int; 2008 May; 73(10):1114-9. PubMed ID: 18272958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased tissue kallikrein levels in type 2 diabetes.
    Campbell DJ; Kladis A; Zhang Y; Jenkins AJ; Prior DL; Yii M; Kenny JF; Black MJ; Kelly DJ
    Diabetologia; 2010 Apr; 53(4):779-85. PubMed ID: 20225398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kallikrein-kinin system: from mediator of inflammation to modulator of cardioprotection.
    Sharma JN
    Inflammopharmacology; 2005; 12(5-6):591-6. PubMed ID: 16259723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
    Messadi-Laribi E; Griol-Charhbili V; Gaies E; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):489-93. PubMed ID: 18307747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema.
    Kita T; Clermont AC; Murugesan N; Zhou Q; Fujisawa K; Ishibashi T; Aiello LP; Feener EP
    Diabetes; 2015 Oct; 64(10):3588-99. PubMed ID: 25979073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulation of biological functions by the Kallikrein-Kinin system].
    Oh-Ishi S
    Yakugaku Zasshi; 1997 Nov; 117(10-11):739-48. PubMed ID: 9414587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallikrein-kinin system in chronic subdural haematomas: its roles in vascular permeability and regulation of fibrinolysis and coagulation.
    Fujisawa H; Ito H; Kashiwagi S; Nomura S; Toyosawa M
    J Neurol Neurosurg Psychiatry; 1995 Oct; 59(4):388-94. PubMed ID: 7561918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kallikrein-kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity.
    Damas J; Garbacki N; Lefèbvre PJ
    Diabetes Metab Res Rev; 2004; 20(4):288-97. PubMed ID: 15250031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy.
    Pruneau D; Bélichard P; Sahel JA; Combal JP
    Curr Opin Investig Drugs; 2010 May; 11(5):507-14. PubMed ID: 20419596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction.
    Chao J; Bledsoe G; Yin H; Chao L
    Biol Chem; 2006 Jun; 387(6):665-75. PubMed ID: 16800727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the discovery and development of drugs targeting the kallikrein-kinin system.
    Wisniewski P; Gangnus T; Burckhardt BB
    J Transl Med; 2024 Apr; 22(1):388. PubMed ID: 38671481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Plasma Kallikrein-Kinin Pathway in the Development of Diabetic Retinopathy: Pathophysiology and Therapeutic Approaches.
    Abdulaal M; Haddad NM; Sun JK; Silva PS
    Semin Ophthalmol; 2016; 31(1-2):19-24. PubMed ID: 26959125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regeneration.
    Westermann D; Schultheiss HP; Tschöpe C
    Int Immunopharmacol; 2008 Feb; 8(2):148-54. PubMed ID: 18182218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular properties of the kallikrein-kinin system.
    Sharma JN; Sharma J
    Curr Med Res Opin; 2002; 18(1):10-7. PubMed ID: 11999140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the plasma kallikrein/kinin system on endothelial cell membranes.
    Røjkjaer R; Schmaier AH
    Immunopharmacology; 1999 Sep; 43(2-3):109-14. PubMed ID: 10596841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.